Choose a Section Interview Spotlights Home News Interview Spotlights Game Changers Fast Facts Interview Spotlights Read more about multiple myeloma isatuximab-irfc melphalan flufenamide dexamethasone daratumumab pomalidomide lenalidomide belantamab mafodotin